HONOLULU (HI Now) - Despite Native Hawaiians and Pacific Islanders (NHPI) especially those with low social economic status are at an increased risk for Alzheimer’s disease. They are often underdiagnosed, undertreated, less well managed and have less access to care especially advanced clinical trial research options. It is therefore Hawaii Pacific Neuroscience’s goal and kuleana to engage, promote, inspire, mentor and invest in the next generations of clinicians and scientists, residents and students in promoting research in underserved minority populations, and lower the barriers to access to care and representation in clinical trials. Hawaii Pacific Neuroscience is particularly excited to partner with the Dept. Native Hawaiian Health to collaborate “laulima” together.
For more information on Hawaii Pacific Neuroscience, visit hawaiineuroscience.com
Copyright 2023 KHNL. All rights reserved.